• No results found

The fate of intracellular peptides and MHC class I antigen presentation Neijssen, J.J.

N/A
N/A
Protected

Academic year: 2021

Share "The fate of intracellular peptides and MHC class I antigen presentation Neijssen, J.J."

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Neijssen, J. J. (2008, February 6). The fate of intracellular peptides and MHC class I antigen presentation. Retrieved from https://hdl.handle.net/1887/12591

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12591

Note: To cite this publication please use the final published version (if applicable).

(2)

The Fate of Intracellular Peptides and MHC Class I Antigen Presentation

J.J. Neijssen

(3)
(4)

The Fate of Intracellular Peptides and MHC Class I Antigen Presentation

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van de Rector Magnificus prof.mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op woensdag 6 februari 2008 klokke 15.00 uur

door

Johannes Jacobus Neijssen geboren te Weert

in 1978

(5)

Referent: Prof. Dr. T. Schumacher Overige leden: Prof. Dr. J. Borst

Universiteit van Amsterdam

Prof. Dr. C. Melief Prof. Dr. W. Moolenaar

Dr. F. Ossendorp

Dr. E.A.J. Reits

Universiteit van Amsterdam

© 2008 J.J. Neijssen

Cover: Johan Strumane |32 charcoal on paper | 2007 |www.johanstrumane.be

The research described in this thesis was performed at the division of Tumor Biology at The Netherlands Cancer Institute (Antonie van Leeuwenhoek Ziekenhuis, NKI/AVL) under the supervision of Prof. Dr. J. Neefjes and supported by grants of the Dutch Can- cer Society (KWF) and the Netherland Organization for Scientific Research (NWO).

Financial support for the publication of this thesis was provided by:

Dutch Cancer Society (KWF), Nederlandse Vereniging voor Microscopie, Genmab B.V.

(6)

Table of contents

Introduction

Chapter 1 MHC class I alleles and their exploration of the antigen-

processing machinery.

Chapter 2 Gap junction-mediated intercellular communication in the immune system.

Peptidase activity in living cells

Chapter 3 Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presenta- tion by MHC class I.

Chapter 4 A major role for TPPII in trimming proteasomal degradtion- products for MHC class I antigen presentation.

Chapter 5 Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: Coupling cytosolic peptide stability to antigen presentation.

Intercellular peptide transfer through gap junctions

Chapter 6 Cross-presentation by intercellular peptide transfer through gap junctions.

Chapter 7 Direct antigen presenatation and gap junction mediated cross-presentation during apoptosis.

Summary

Nederlandse samenvatting List of Publications

Curriculum vitae Color figures

9

29

45

59

73

83

91

103 105 107 109 111

(7)

Referenties

GERELATEERDE DOCUMENTEN

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Genome-wide Multi-Dimensional RNAi Screen Reveals Pathways Controlling MHC Class II Antigen Presentation (Cell, In Press,

When shed by DC, exosomes can present antigen in context of MHC-II to activated T cells or T cell lines directly (Arnold and Mannie, 1999) or indirectly to naïve T cells

We first determined the interaction, expressed as Donor FRET efficiency (E D ) between two tetraspanin proteins – CD63 and CD82 – when predominantly present at

By integration information of three databases, the MHC-II cell surface expression database, the mRNA expression database and the MHC-II trafficking database, we could

Peptide transfer from an apoptotic cell was tested by co-cul- turing A431+/-Cx43 stably transfected with FKBD-Casp9, and transiently transfected with mRFP-Ub-DEVD-SIINFEKL with

Peptiden, gemaakt in apoptotische cellen, kunnen nog steeds gepresenteerd worden in de MHC klasse I route van deze stervende cellen.. Ook kunnen ze inderdaad in naburige

Doordat peptiden via gap junctions tussen cellen diffunderen, kunnen onschuldige cellen door het afweersysteem worden aangevallen4.